CYTO Stock Summary and Trading Ideas (Altamira Therapeutics Ltd. - Common Shares | NASDAQ:CYTO)

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

Altamira Therapeutics Ltd. - Common Shares trades on the NASDAQ stock market under the symbol CYTO.

As of February 7, 2025, CYTO stock price was flat at $0.30 with million shares trading.

CYTO has a market cap of $1.13 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CYTO traded as high as $860.00 and as low as $.30.

CYTO has underperformed the market in the last year with a return of -83.3%, while the SPY ETF gained +22.0%. In the last 3 month period, CYTO fell short of the market, returning -40.6%, while SPY returned +1.2%. However, in the most recent 2 weeks CYTO has outperformed the stock market by returning 0.0%, while SPY returned -1.2%.

CYTO support price is $.30 and resistance is $.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CYTO shares will trade within this expected range on the day.